UiPath's annual report admits AI lets companies build such tools themselves.
Is it a good business? · 6 · What does its record show?
Growth slowed as losses turned to profit
Sales, $B
0.9
1.1
1.3
1.4
1.6
1.7
Jan 2022Jan 2023Jan 2024Jan 2025Jan 2026last 12 mo
Sales$892M → $1.72Bsales, year to January 2022 to the past year
Profit−56% → 8.9%operating profit per $1
Share pay58% → 14%of revenue paid in shares
Much of the profit gain came from share pay falling; with the core near 4% growth, more must come from costs.
Is it a good business? · 7 · How much room is there to grow?
The robot market is small and mostly won
$2.9BGartner's count of the robot market, 2022
About $1.94BUiPath's recurring revenue a year
37%of large US companies now use AI
Management's $142B estimate counts work AI might do, not software bought today.
Is it a good business? · 8 · Who is in charge?
The founder runs it again
2005Daniel Dines founded UiPath
19.6%of the shares he owns, and 84.6% of the votes
September 2026Hitesh Ramani, promoted from inside, became finance chief
Dines holds the votes, so he decides the company's direction.
The story right now · 9 · Can AI do the robots' job?
New AI can work a screen itself
Over $250MAI sales a year, management says; not in its filings
UiPath's robots follow recorded steps. New AI models can look at a screen and decide the steps themselves, which could make the robots less needed or more useful.
The story right now · 10 · How would AI damage show?
Customers would spend less on robots
AI does the jobFewer robots needed.
Renewals shrinkSpending per customer falls.
Growth slowsCore near 4%.
Or AI sells moreOver $250M claimed.
If AI models do the robots' job, spending per customer will show it before the company's forecast does.
The story right now · 11 · What changed lately?
Revenue up 13.4%, then a slower forecast
$410.3Mrevenue in the quarter
$31.6Moperating profit, standard accounting
About 7.6%growth forecast for next quarter
16.6%share fall the day after
Mixed quarter
Part of the AI sales came with WorkFusion, a company UiPath bought.
The story right now · 12 · What is everyone arguing about?
Hollowed out by AI, or sticky robots?
Many investors think
Old robot software AI will hollow out
We think
Sticky robots, but priced above our value
Only 3 of 21 analysts rate it a buy, and a quarter of traded shares are borrowed and sold by those betting on a fall.
The price and our view · 13 · What is a share worth?
The price sits above even our best case
$9.46what we think a share is worth · the last close is of that
$9.46our value
Attractive below $7.57
Neutral
Unattractive above $11.35
$6.51gloomy: growth halves, less kept per $1
$9.46our estimate: experts' path, then slowing
$11.29sunny: growth beats the forecast by a quarter
Value per share in three futures. None is a prediction of the share price.
We estimate what a share is worth from the cash the business should earn over many years. Our rule: buy only when the price is at least a fifth below our estimate, as a cushion for being wrong.
The price and our view · 14 · How could we be wrong?
AI could do the robots' job
AI does the robots' jobBiggest
Screens without robots.
Slower growthShowing now
About 7.6% next quarter.
Microsoft bundlesWatch
Its own robots.
AI salesUnknown
Not filed.
The robot market is small and UiPath already holds much of it.
The price and our view · 15 · How will we know?
2 December tests spending per customer
Spending per customer holdsGood sign
AI sales are filedGood sign
Growth falls below 7%Bad sign
DEC 20262
Third-quarter fiscal 2027 results, 2 December. Companies report every three months; each report is a test of the story.
Our view also changes on price alone: if the shares fall to within a fifth of our estimate, we move to Neutral.
The price and our view · 16 · So, what do we think?
Sticky robot software, with AI products still small
$9.46our value
Attractive below $7.57
Neutral
Unattractive above $11.35
UnattractiveHigh conviction
UiPath sells software that does repetitive office work, and has cash and no debt. But the core grows slowly, AI models that work a screen are a threat, and the price sits above even our sunny future.
↑ ↓ to move · C for contents
What it does
More about the company
Who it is
Big companies run on old systems that do not talk to each other, so staff copy data between screens all day. UiPath's software robots do that copying instead: a developer records the steps once and the robot repeats them, logging every click.
Its buyers are mostly banks, insurers, governments and manufacturers; 387 of them spend more than $1M a year. It now also sells AI agents that read documents and decide the next step.
How it makes money
Customers pay a yearly licence or subscription, mostly for how many robots and how much of the platform they use, and most renew and add more. About $1.38B of signed contracts are still to be delivered.
Delivering software costs little, so most of each dollar is left over. The catch has been paying staff in shares: over the last year that cost took about two-thirds of the spare cash, though it is now falling fast.
Growth and profit
What growth costs
Growth has been making UiPath more profitable. Sales have risen by more than half since 2023 while spending on selling stayed flat, and paying staff in shares has shrunk fast. The catch is that the easy gains are mostly taken: with the core growing slowly, more profit now has to come from holding costs down rather than from selling more.
Its record
The numbers
Is it growing?Steady
Sales grew 15% over the twelve months to Jul 2026, about the same pace as the 13% in the year to Jan 2026.
Is it profitable?Thin
Operating margin is 8.9%, up from −13% in the year to Jan 2024.
Does growth pay off?Pays off
Running costs take 74¢ of each sales dollar, down from 137¢ in the year to Jan 2022.
Does it earn good returns?Low
Each dollar put into the business earns 8.5% a year after tax, up from 2.9% in the year to Jan 2026.
Is it making cash?Strong
It turned 21% of sales into free cash, $363M over the last twelve months.
How steady is it?Uneven
Yearly sales growth has ranged from +9.3% to +47% over the last 5 years.
Are shares being diluted?Diluting
The share count rose 15% in 4.5 years, and pay in shares costs 14% of sales.
Why it wins
The evidence
A large customer may have hundreds or thousands of robots built in UiPath's tools, each tuned to its own screens and rules. Moving them to a rival means rebuilding and re-testing every one, so customers mostly add rather than leave: existing customers spend $1.09 for every dollar they spent a year ago.
That wall is getting lower. AI coding tools make rebuilding cheaper, and UiPath itself is using them to move a big Canadian bank's robots over from a rival. What helps UiPath win can help a rival win back.
Who could beat it
The rivals in full
AI models can now work a computer screen themselves: Anthropic sells a tool that lets its model look at the screen and use the mouse and keyboard, the robot's job. Microsoft bundles its own robot software, and UiPath's annual report admits AI lets companies build what they used to buy. UiPath answers that a model is slower, can be wrong and still needs something to run and check it.
UiPath's agents and Maestro's orchestration for processes that already run inside ServiceNow's workflow platform
Appian and Pegasystems process platformsAPPNPEGA
Maestro Case and Maestro's orchestration of long, exception-heavy processes, which both rivals sell as case management with AI added
Automation Anywhereprivate
UiPath's robots and its agent builder in a head-to-head tender for a company's automation estate
How big it could get
The market and who has signed
The market
The robot market is not large. The last outside count, from the research firm Gartner, was $2.9B for 2022, and UiPath alone now has about $1.94B a year of recurring revenue, so it already holds much of it.
The bigger hope is AI. The Census Bureau finds 37% of US companies with 250 or more staff now use AI, but nobody counts what they spend on agents. Management's $142B estimate counts work AI might do, not software bought today.
Who runs it
Leaders, pay and the cash
Who runs it
Daniel Dines founded UiPath in 2005 and runs it again after two years sharing the job and a brief step aside; a new finance chief, promoted from inside, took over in September. Dines owns about a fifth of the company and, through special shares, more than four-fifths of the votes, so outside shareholders cannot overrule him. He takes almost no pay. The other officers' bonuses ride on growing yearly subscriptions and on cash, not on profit after the cost of paying staff in shares.
What they did with the money
It spent $268.5M buying back 22.8M of its own shares in the first half, at about $11.28 each, and $160M in cash on WorkFusion. Paying staff in shares fell to $98.3M from $154.4M a year earlier, so the share count is now shrinking.
The last report
The latest report
UiPath's Q2 fiscal 2027 revenue rose 13.4% to $410.3M, beating its own guide
What it did to the thesis Mixed quarter
It confirmed the business is profitable and customers are spending more, but the guide for the next quarter showed growth slowing, and the AI products' size is still only management's word, so the question of how big they are stayed open.
The report
In Q2 fiscal 2027, the three months to July, revenue rose 13.4% to $410.3M and recurring revenue 12.4% to $1.94B. UiPath made $31.6M of operating profit under the official accounts, against a loss a year earlier, and existing customers spent more.
The problem was the guide. Management expects about 7.6% growth in Q3, and on the call it said AI products had passed $250M a year without filing the figure. Part of that came from WorkFusion, a company it bought in February.
What's happening now
The background
The shares fell 16.6% the day after the results, on the slower guide and an analyst's question about a new AI model that does office workflows, and kept falling: 28% in a month.
The market's view is now gloomy. Only 3 of 21 analysts say buy, and a quarter of the shares that trade are sold short, bets that the price will fall. When that many people expect the worst, the next results can matter more than usual.
Where we disagree
Both sides in full
The market
Old robot software that AI models will hollow out: only 3 of 21 analysts rate it a buy.
We believe
The robots are sticky and cash per share is rising, but the price is above our three-stage value of the business.
The argument
The market reads one quarter's guide. The filed numbers say existing customers are spending more, large customers grew 21% in a year, and share pay is falling fast.
The case against us is the threat itself: if AI models do the robots' job well enough, customers will stop renewing, and spending per customer, not the guide, will show it first.
What it's worth
How we value it
Valued on the analysts' revenue path for three years, each later year closing 30% of the gap to 4%, on official operating profit with stock pay a cost and tax paid in full; the thesis's own evidence is the check on that path.
What the price assumes
Sales growth in the first year, then slowing as ours does, at the same profit per sale.
The price assumed
28.2%
Our estimate
8%
Measured at the close of
6 Nov 2026
The three cases
Bear case$6.51
Growth runs at half the analysts' path, 4% and 4%, the margin settles a fifth lower at 11.5%, and new capital earns only the 8% rate: the downturn test.
Our value$9.46
Revenue grows 8% and 8% over three years, the analysts' path (C57), then fades toward 4%, closing 30% of the gap each year; the margin moves to 14.4%, the analysts' year-three figure after stock pay and on the filed basis (7.1% less).
Bull case$11.29
Growth runs a quarter above the analysts' path, 10% and 10%, the margin reaches 15.8%, and new capital earns 15%.
The bet
Seen as a bet
The bet is on the AI products alone: agents, document reading and the software that coordinates them. The robot business is counted separately, at what its closest rival is worth for each dollar of sales.
Even if the AI products keep growing fast for two more years, the whole company ends up worth only a little more than today, so it is an expensive bet. But if they stall, the robot business and the cash still cover most of the price, which makes the downside small.
What could go wrong
Every risk
The risks
AI models do the job
Models that work a screen themselves, from Anthropic and others, could replace the robots, and Microsoft bundles its own robot software with products customers already buy.
The core is slowing
The old robot business grows about 4% a year, and the guide for Q3 fiscal 2027 implies total growth of about 7.6%.
AI figures are unchecked
The $250M of AI products is management's spoken figure, not filed, and part of it was bought with WorkFusion.
One man holds the votes
The founder holds about 84% of the votes, so other shareholders cannot force a sale or a change of course.
Share pay could rise again
Paying staff in shares took $290.7M in fiscal 2026; new grants to four executives in September could push it back up.
What we still do not know
How much of the AI products is new agents rather than older document reading, and how much came with WorkFusion.
How many customers have already moved screen work to an AI model's agent instead of a robot.
How much spending customers keep each year before they add more; UiPath files only the figure after additions.
What changes our view
Every route to a new view
Every route to a new view
→ Neutral
The share price falls to about $11.35, back within 20% of what we think the business is worth.
→ Attractive
The share price falls to about $7.57, 80% of what we think the business is worth.
→ Attractive
UiPath reports AI products of $400M a year or more. Existing customers spend $1.12 or more for every dollar they spent a year earlier.
The next test
It supports the case if
ARR at or above $1.992B and dollar retention at or above 109%.
It pressures the case if
ARR below $1.992B or dollar retention below 109%.
We would also be wrong if
The AI products grow less than 30% in a year.
Paying staff in shares rises back above $250M a year.
The verdict
Scores and how we weighed it
The scores
Growth
3 of 4
Business quality
3 of 4
Financial position
4 of 4
Execution record
3 of 4
Per share capture
3 of 4
Potential
2 of 4
Risk profile
3 of 4
Valuation
1 of 4
Evidence quality
3 of 4
How we weighed it
ValueNegative
The price sits above our value and above the bull case.
BusinessPositive
A solid business: customers keep adding to it, with cash and no debt.
GrowthNegative
The core grows slowly and the guide shows growth slowing.
RisksNegative
AI models may do the job directly, the core is slowing and the AI figures are unchecked.
RivalsMixed
Between its two rivals on spare cash, so the price is the group's.
The groupMixed
It sits in none of our ranked groups; AI news moves it.
Latest newsMixed
The last report confirmed profit but guided slower growth.
In plain words
Our estimate of value
We forecast how much cash the business can earn over the next ten years and beyond, then ask what that stream is worth today to an investor who wants an 8% yearly return. We do it three times: a gloomy future, an expected one and a sunny one. We call a share Attractive only when its price is at least 20% below the expected estimate, and Unattractive when it is 20% above.